BOSTON THERAPEUTIC USD0.001 (BTHE)

0.08
OTC Markets
Prev Close 0.09
Day Low/High 0.08 / 0.08
52 Wk Low/High 0.03 / 0.17
Exchange OTC Markets
Shares Outstanding 45.51B
Market Cap 4.10M
Div & Yield N.A. (N.A)

SeeThruEquity Issues Quarterly Update On Boston Therapeutics

SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a quarterly update on Boston...

[video] New Tablet From Boston Therapeutics Reduces Sugar Intake for Diabetics

Boston Therapeutics new PAZ320 tablet is designed to reduce a person's sugar intake before eating a meal.

Boston Therapeutics' New Tablet Reduces Sugar Intake for Diabetics

Boston Therapeutics new PAZ320 tablet is designed to reduce a person's sugar intake before eating a meal.

Boston Therapeutics, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com

Company invites individual and institutional investors to log-on to view presentation